KBC Group
TWST icon

KBC Group’s Twist Bioscience TWST Stock Holding History

KBC Group’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$410K Hold
2,121
– – ﹤0.01% 809
2026
Q2 		$218K Hold
2,121
– – ﹤0.01% 1008
2026
Q1 		$101K Hold
2,121
– – ﹤0.01% 1318
2025
Q4 		$67K Hold
2,121
– – ﹤0.01% 1524
2025
Q3 		$60K Hold
2,121
– – ﹤0.01% 1582
2025
Q2 		$78K Sell
2,121
-985
-32% -$34K ﹤0.01% 1369
2025
Q1 		$122K Buy
3,106
+164
+6% +$7.39K ﹤0.01% 1370
2024
Q4 		$137K Buy
2,942
+1,226
+71% +$55.4K ﹤0.01% 1353
2024
Q3 		$78K Hold
1,716
– – ﹤0.01% 1454
2024
Q2 		$85K Hold
1,716
– – ﹤0.01% 1267
2024
Q1 		$59K Buy
1,716
+570
+50% +$20.6K ﹤0.01% 1454
2023
Q4 		$42K Hold
1,146
– – ﹤0.01% 1655
2023
Q3 		$23K Buy
+1,146
New +$25.2K ﹤0.01% 1866

Other funds holding TWST

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
ARK Investment Management
ARK Investment Management St. Petersburg, Florida $17.4B AUM 41.01% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $54.9B AUM 27.38% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return

KBC Group's TWST Position: Q3 2026 in Review

KBC Group held its Twist Bioscience (TWST) position steady in Q3 2026 at 2,121 shares worth $410K. The position accounts for ﹤0.01% of the portfolio, ranked #809.

KBC Group first reported a position in TWST in Q3 2023 and has held it in 13 quarters since. 330 funds tracked by Wall St. Rank hold TWST as of Q3 2026.

  • KBC Group held 2,121 shares of Twist Bioscience worth $410K as of Q3 2026.
  • KBC Group left its Twist Bioscience share count unchanged in Q3 2026.
  • Twist Bioscience made up ﹤0.01% of KBC Group's portfolio in Q3 2026, its #809 holding.
  • KBC Group first reported a position in Twist Bioscience in Q3 2023 and has held it in 13 quarters since.
  • 330 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2026.

Based on KBC Group's 13F filing for Q3 2026, filed 22 Oct 2026.